The study of Liu et al., indicated that Astragalus polysaccharide could regulate part of the insulin signaling in insulin-resistant skeletal muscle, and could be a potential insulin sensitizer for the treatment of type 2 diabetes [99]. This evidence concerns the gene INS and type 2 diabetes mellitus.